News

March 12, 2019March 12, 2019

Mobile Technologies May Help JIA Patients Manage Health, Study Reports

News

Mobile health technologies may help people with juvenile idiopathic arthritis (JIA) keep track of their health status and communicate with their physicians, improving their ability to make informed decisions ... Read more

March 8, 2019March 8, 2019

Spanish Survey Reveals Pediatricians’ Misconceptions About JIA

News

Approximately half of pediatricians and pediatric residents in Spain have wrong beliefs and misconceptions about the incidence and manifestation of juvenile idiopathic arthritis, a national survey showed. The findings ... Read more

March 5, 2019March 5, 2019

Genentech’s Actemra Not Linked to Higher Risk of Infection in Children With sJIA or pcJIA, Trials Show

News

Genentech‘s Actemra (tocilizumab), a medicine approved for the treatment of certain types of juvenile idiopathic arthritis (JIA), is not linked to a higher risk of infections in children with systemic juvenile ... Read more

February 27, 2019February 27, 2019

Tacrolimus May be Effective Therapeutic Option for Children With SOJIA, Small Study Says

News

Tacrolimus, an investigational immunosuppressive treatment, may be an effective therapeutic option for children and adolescents with systemic-onset juvenile idiopathic arthritis (SOJIA), a study says. The study, “Treatment of patients ... Read more

February 19, 2019February 19, 2019

Children with JA Plus Enthesitis Report Worse Pain, Quality of Life, Canadian Study Finds

News

Children with juvenile arthritis who also have enthesitis have worse quality of life, impaired function, and higher pain intensity according to self-reported outcomes, a large-scale study shows. The study, ... Read more

February 15, 2019February 15, 2019

More JIA Children Participate in School Sports Likely Because of Better Treatment Options, Study Shows

News

More children and teenagers with juvenile idiopathic arthritis (JIA) have participated in school sports over the past 15 years, which is likely explained by better treatment options that improved their functional abilities, ... Read more

February 12, 2019February 12, 2019

Study Examines Discontinuing Use of TNF-inhibitors Prior to Week 20 of Pregnancy in JA, RA Patients

News

Pregnant women with well-controlled juvenile idiopathic arthritis and rheumatoid arthritis, and who discontinue treatment with TNF inhibitors prior to week 20 of pregnancy, do not experience worsening of their ... Read more

February 8, 2019February 8, 2019

Time Between Dye Administration, MRI Can Affect Synovial Thickness

News

How thick the synovial membrane (the layer of tissue that lines joints) appears in an MRI image after administration of a contrast-enhancing dye is time-dependent, a study shows. The ... Read more

February 5, 2019February 5, 2019

Interleukin-1 Inhibitors Show Excellent Retention Rates in sJIA Patients

News

Sobi‘s Kineret (anakinra) and Novartis‘ Ilaris (canakinumab), two interleukin-1 inhibitors that have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of systemic onset juvenile arthritis ... Read more

Pin It on Pinterest